Adjuvant (adj) bevacizumab (B) plus dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-p) in early stage breast cancer (BC) patients (pts): Cardiac safety Meeting Abstract


Authors: Dickler, M. N.; Traina, T.; Panageas, K.; Steingart, R.; Dang, C.; Fornier, M.; Sugarman, S.; Norton, L.; Hudis, C.; Rugo, H.
Abstract Title: Adjuvant (adj) bevacizumab (B) plus dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-p) in early stage breast cancer (BC) patients (pts): Cardiac safety
Meeting Title: 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 25
Issue: 18 Suppl.
Meeting Dates: 2007 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2007-06-20
Start Page: 19s
Language: English
ACCESSION: WOS:000455043700092
PROVIDER: wos
Notes: Meeting Abstract: 567 -- Source: Wos
MSK Authors
  1. Clifford Hudis
    848 Hudis
  2. Larry Norton
    581 Norton
  3. Chau Dang
    161 Dang
  4. Maura N Dickler
    238 Dickler
  5. Richard M Steingart
    116 Steingart
  6. Monica Nancy Fornier
    136 Fornier
  7. Tiffany A Traina
    154 Traina
  8. Katherine S Panageas
    331 Panageas